eGERD
A novel device for a billion people suffering from Reflux, Heartburn & Regurgitation
GERD
Gastro Esophageal Reflux Disease [GERD] is one of the most common digestive disorders, affecting a billion people globally who suffer from reflux, heartburn and regurgitation.
GERD main complications are Barrett disease and esophageal cancer.
Data-Driven, Remote & Personalized Treatment
Proprietary smartphone application controls the eGERD device and generates clinical data securely stored on the GerdCare cloud.
Collected data is processed to create personalized and optimized treatment.
How It Works
The eGERD is a digital therapeutic electro-stimulator, generating modulated asymmetrical electrical bursts of pulses synchronized with breathing. Abdominal muscles are contracted in an asymmetrical manner inducing improvement in the functionality of the Lower Esophagel Sphincter [LES] and reducing acid reflux from the stomach to the esophagus.
eGERD platform
A novel, unique, drug-free, non-invasive, user friendly medical platform designed for alleviating symptoms of GERD. No preparations are required prior to usage. It is set to immediate use, anytime, anywhere by any GERD patient.
-20230430-02.png)
-20230430-02.png)
eGERD Device
Bluetooth
WiFi/Cellular
Proprietary SmartPhone App
Cloud Storage
WiFi/LAN
Desktop Client
Clinical Results
75%
Reduction in
Acid Exposure & DeMeester score
within a few days of device use
Reduction in
Heartburn & Regurgitation
75%
within a few days of device use
Multi-Center Pilot Study publication
"Conclusion: eGERD (TESS) is effective in reducing both symptoms and esophageal AET in GERD patients"
Reduction in
Acid Exposure & DeMeester score
90%
within a few days of device use
Proof-of-Concept Clinical Study publication
"Conclusion: eGERD (TESS) is a safe and potentially effective modality in reducing esophageal-acid exposure in GERD patients unresponsive to standard-dose PPI"
eGERD benefits
Rapid Symptoms Relief
Drug Free
Non Invasive
Affordable
Self Use
Safe
Safety and Effectiveness Clinically Proven
Global Market
$4.6B
1 Billion people
affected by GERD
$2.75B
PPI drugs market
USA Market
$1.3B
$24B direct & indirect annual economy burden
67M
Americans diagnosed with GERD
Current solutions
PPI drugs
-
PPI treatment for GERD is ineffective for up to 40% of patients using the drug.
-
Chronic use of PPI’s reduces stomach acidity levels, impairing nutrient absorption; Other long-term risks include Osteoporosis, Neurological Disorders, Dementia, Kidney disease and Cancer.
Surgical procedures [Fundoplication, LINX]
-
Low acceptance rate due to inavsiveness, associated risks and long recovery.
About Us
GerdCare Medical is a digital therapeutic company developing a unique and novel drug-free solution for treatment of Gastroesophageal Reflux Disease [GERD]. The eGERD is a non-invasive medical device, clinically proven to be safe & effective. The eGERD is a self-use wearable device. It can be used anytime, anywhere.
Meet The Management Team
Dr. Shimon Eckhouse
Chairman
Prominent serial entrepreneur and investor in companies such as Syneron, Lumenis and Ventor [acquired by Medtronic]
David Hanuka, MBA
CEO
Entrepreneur, inventor and medical device industry executive, introducing a wide range of medical technologies to market, strategic collaborating and M&A’s.
Giora Arbel
Co-Founder, VP of R&D
M.Sc. in engineering and Operation Research. 45+ years of R&D management experience in Aeronautics and medical devices, including development of electrical stimulators
Moti Esh, MD
Co-Founder, CTO
Both a physician and an engineer, Dr. Esh has 40+ years of development and engineering experience in medical devices, including developing electrical stimulators
Meir Or, M.Sc.
Product Manager
Experienced R&D team leader in medical device development, with strong multidisciplinary background. B.Sc. and M.Sc. Biomedical Engineering.
Ester Pri-Or
Clinical Operations Mgr.
A certified nurse with over 15 years of experience managing clinical research in several medical device companies
Contact Us
3 Hatnufa street, 7th floor, High-tech Park, Yokneam Ilit
Israel, 2069207
Dr. M. Esh:
Managment Team
David Hanuka, MBA
CEO
Entrepreneur, inventor and medical device industry executive, introducing a wide range of medical technologies to market, strategic collaborating and M&A’s.
Ester Pri-Or
Clinical Operations Mgr.
A certified nurse with over 15 years of experience managing clinical research in several medical device companies
Moti Esh, MD
Co-Founder, CTO
Both a physician and an engineer, Dr. Esh has 40+ years of development and engineering experience in medical devices, including developing electrical stimulators
Giora Arbel
Co-Founder, VP of R&D
40+ years of R&D management experience in medical devices including managing the development of electrical stimulators